Case Study | Igor F. Palacios, M.D., Roberto J. Cubeddu, M.D. , Christian Witzke, M.D., Angel Caldera, M.D.
A 55-year-old woman with a history of heavy alcohol use, hepatitis C induced cirrhosis, hypertension, and chronic renal insufficiency presented at Massachusetts General Hospital in Boston Mass., with nine months of increasing intermittent substernal chest pressure. The pain was inducible by exertion, was nonradiating, and when present associated with shortness of breath, and diaphoresis.
September 17, 2009
Feature | Dave Fornell
In August Daiichi Sankyo and Eli Lilly and Company launched U.S. sales of Effient (prasugrel), a new antiplatelet medication to prevent stent thrombosis, which clinical studies show to be more effective and better tolerated than Plavix (clopidogrel).
September 17, 2009
Feature | Dave Fornell
Ruptured vulnerable plaque (VP) is blamed for the majority of acute myocardial infarctions and many strokes, but there is extensive debate over which modalities are best suited to detect these plaques, and there is as of yet no conclusive way to determine which of these plaques will rupture.
September 17, 2009Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Stents Bifurcation | Dave Fornell
Stenting of lesions at coronary vessel bifurcations is one of the most challenging percutaneous interventions, along with a high risk of procedural complications and restenosis. Several companies are developing specialized bifurcation stents to help make the job easier. Currently there are no dedicated bifurcation stents with FDA clearance.
September 17, 2009
News
September 17, 2009 - Inflation rates for healthcare supplies are projected to remain unchanged through 2010, according to an analysis released by the Premier healthcare alliance.
September 17, 2009
Feature | Dave Fornell
Over the past year several new drug-eluting stents (DES) stents have been released and SYNTAX trial data proved DES compare as well as coronary artery bypass graft surgery (CABG) in patient outcomes. DES vs. CABG
September 17, 2009Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Stents Bioresorbable | Dave Fornell
Metal stents are foreign objects that can irritate vessels and cause stent thrombosis, prevent vessel remodeling, prevent future surgical interventions, can fatique and suffer strut fractures, and impair CT or MR imaging. For these reasons several stent manufacturers are working on biodegradeble stents that do not leave behind any hardware.
September 17, 2009
News
September 17, 2009 - The Senate Finance Committee reduced the imaging utilization assumption rate from 90 percent to 65 percent, in essence cutting the originally proposed utilization increase by nearly two-thirds.
September 17, 2009
News
September 17, 2009 - Lantheus Medical Imaging Inc. today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging cardiac neuronal function, in healthy subjects, undergoing positron emission tomography (PET) imaging.
September 16, 2009Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature | Dave Fornell
The polymer coating on drug-eluting stents (DES) used to carry the antiproliferative drugs cause an increased risk of stent thrombosis, months or even years after a stent is implanted. This has led stent manufacturers to look for or ways to eliminate the vessel irritating polymers for better biocompatibility usually associated with bare metal stents (BMS).
September 16, 2009
News
September 16, 2009 – Guided Delivery Systems Inc. (GDS) announced the first successful percutaneous implantation of the GDS Accucinch System for mitral valve repair.
September 16, 2009
News
September 16, 2009 - Medrad will host a breakfast symposium, “Complete Thrombus Management During Rapid STEMI Intervention,” during TCT 2009, starting at 6:30 a.m. Thursday, Sept. 24, in Moscone Center, room 130.
September 16, 2009Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
September 16, 2009 – Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, Texas plans to create a worldwide electrophysiology (EP) telecardiology network for live consultations with other EP labs anywhere in the world using the Odyssey Network offered by Stereotaxis.
September 16, 2009
News
September 15, 2009 – EVEREST registry clinical results of the MitraClip therapy for patients with mitral regurgitation (MR) will be a big topic of discussion at the Transcatheter Cardiovascular Therapeutics (TCT) Conference Sept. 21-25 in San Francisco.
September 16, 2009
News
September 16, 2009 – MemorialCare Heart and Vascular Institute at Long Beach Memorial Medical Center (LBMMC) in Long Beach, Calif., said it implanted a new, heart attack detection device in two heart attack survivors yesterday.
September 16, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now